0 Комментарии
0 Поделились
733 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Reels
-
Статьи пользователей
-
Маркет
-
Offers
-
Jobs
-
Войдите, чтобы отмечать, делиться и комментировать!
-
High Potency API Market Trends Influencing Next-Generation Pharmaceutical SolutionsThe rise of high potency APIs is reshaping the pharmaceutical landscape, leading to a notable increase in market volume. Projections indicate that the High Potency API market is set to reach a substantial size of USD 38.03 billion by 2035. This growth trajectory is driven by the increasing demand for targeted therapies, particularly in oncology, where high potency APIs play a critical role in...0 Комментарии 0 Поделились 521 Просмотры 0 предпросмотр
-
Latanoprost API: Powering Glaucoma Treatment Through Advanced Pharmaceutical ManufacturingThe Latanoprost API Market was valued at USD 1,050.9 million in 2025 and is projected to grow to USD 1,500 million by 2035, registering a CAGR of 3.6% during the forecast period. This steady growth trajectory reflects the essential role of latanoprost active pharmaceutical ingredients in addressing the demand for effective glaucoma treatments, improved patient outcomes, and innovative...0 Комментарии 0 Поделились 416 Просмотры 0 предпросмотр
-
North America Acarbose API Market: Emerging Pharmaceutical Industry TrendsThe North America acarbose API market is driven by the region’s established pharmaceutical sector and continued need for diabetes-management medicines. The US represents the leading market in the region, while regulatory requirements, API quality standards, and diversified pharmaceutical supply networks are shaping opportunities for manufacturers and suppliers. The acarbose API market...0 Комментарии 0 Поделились 331 Просмотры 0 предпросмотр
-
Oligonucleotide API Market – RNA-Based Therapeutics Driving Pharmaceutical Manufacturing GrowthMarket Overview The oligonucleotide API market is expanding rapidly as pharmaceutical manufacturers scale up production of active pharmaceutical ingredients supporting RNA-based therapeutics such as antisense oligonucleotides and siRNA drugs. These therapies target genetic mechanisms directly, offering treatment options for previously undruggable conditions. Growth is driven by increasing...0 Комментарии 0 Поделились 579 Просмотры 0 предпросмотр
-
Global Cefalexin API Market to Reach USD 871 Million by 2034According to a new report from Intel Market Research, the global Cefalexin API market was valued at USD 571 million in 2024 and is projected to reach USD 871 million by 2034, growing at a robust CAGR of 6.4% during the forecast period (2025–2034). This growth is propelled by the increasing prevalence of bacterial infections, rising demand for generic antibiotics, and expanding...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Global Ibuprofen Market Growing at 2.9% CAGR Through 2032According to a new report from Intel Market Research, the global ibuprofen market was valued at USD 87.4 million in 2024 and is projected to grow from USD 89.9 million in 2025 to USD 106 million by 2032, exhibiting a steady CAGR of 2.9% during the forecast period (2025–2032). This growth is driven by the increasing global burden of chronic pain conditions and inflammatory diseases, rapid...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Global Microbial Fermentation APIs Market Growing at 1.5% CAGR Through 2032According to a new report from Intel Market Research, the global Microbial Fermentation APIs market was valued at USD 27.57 billion in 2024 and is projected to reach USD 30.56 billion by 2032, exhibiting a steady CAGR of 1.5% during the forecast period (2025–2032). This growth is driven by the increasing demand for antibiotics, amino acids, and vitamins, particularly in emerging economies...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Pharmaceutical Contract Manufacturing Market Size and Future Revenue PotentialThe pharmaceutical industry is changing how medicines move from development to commercial production. Instead of building every manufacturing capability internally, drug developers are increasingly relying on specialized external partners to manage production, improve operational efficiency, and respond to evolving treatment requirements. This shift is strengthening the pharmaceutical contract...0 Комментарии 0 Поделились 692 Просмотры 0 предпросмотр
-
Pharmaceutical Supply Chain Management (SCM) Market: Supplier Management, Logistics & Growth TrendsPharmaceutical Supply Chain Management (SCM) Market: Growth, Trends, Demand & Forecast to 2033 Pharmaceutical Supply Chain Management (SCM) Market Overview The global Pharmaceutical Supply Chain Management (SCM) Market is experiencing strong growth as pharmaceutical companies seek greater visibility, resilience, compliance, and efficiency across increasingly complex supply...0 Комментарии 0 Поделились 4Кб Просмотры 0 предпросмотр
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek